We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
+4.65%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
–
AUM
$418M
AUM Growth
-$30.8M
Cap. Flow
-$37.5M
Cap. Flow %
-8.97%
Top 10 Hldgs %
54.35%
Holding
163
New
44
Increased
31
Reduced
48
Closed
39

Top Buys

Rank Stock Value
1
SRGA
Surgalign Holdings, Inc. Common Stock
SRGA
+$3.75M
2
DISCK
Discovery, Inc. Series C Common Stock
DISCK
+$3.59M
3
TECK icon
Teck Resources
TECK
+$3.58M
4
BPOP icon
Popular Inc
BPOP
+$3.3M
5
GTS
Triple-S Management Corporation
GTS
+$3.17M

Top Sells

Rank Stock Value
1
TAP icon
Molson Coors Class B
TAP
+$3.57M
2
UGI icon
UGI
UGI
+$3.26M
3
UHS icon
Universal Health Services
UHS
+$3.1M
4
WFC icon
Wells Fargo
WFC
+$3.08M
5
BBCP icon
Concrete Pumping Holdings
BBCP
+$2.9M

Sector Composition

Rank Sector Weight
1 Financials 9.06%
2 Industrials 7.6%
3 Materials 7.59%
4 Consumer Discretionary 5.8%
5 Healthcare 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DIN icon
26
Dine Brands
DIN
$452M
$3.35M 0.8%
37,582
-6,630
-15% -$614K
SRGA
27
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$3.27M 0.78%
78,452
+73,298
+1,422% +$3.75M
LAZ icon
28
Lazard
LAZ
$4.31B
$3.24M 0.78%
71,695
-1,457
-2% -$66.8K
BPOP icon
29
Popular Inc
BPOP
$11.1B
$3.23M 0.77%
+43,078
New +$3.3M
HYRE
30
DELISTED
HyreCar Inc. Common Stock
HYRE
$3.21M 0.77%
153,259
-154,129
-50% -$2.37M
CVEO icon
31
Civeo
CVEO
$318M
$2.98M 0.71%
167,626
+38,167
+29% +$639K
LRN icon
32
CALL
Stride
LRN
$3.43B
$2.96M 0.71%
+92,100
New +$2.75M
FE icon
33
FirstEnergy
FE
$27.5B
$2.96M 0.71%
79,430
-6,689
-8% -$249K
TBI
34
Trueblue
TBI
$311M
$2.88M 0.69%
102,338
+80,966
+379% +$2.16M
GDX icon
35
CALL
VanEck Gold Miners ETF
GDX
$27.4B
$2.85M 0.68%
60,900
-355,400
-85% -$13M
CSTE icon
36
Caesarstone
CSTE
$79.5M
$2.83M 0.68%
191,701
-53,459
-22% -$808K
RMR icon
37
The RMR Group
RMR
$332M
$2.82M 0.67%
72,886
+24,021
+49% +$957K
KGC icon
38
CALL
Kinross Gold
KGC
$32.8B
$2.67M 0.64%
420,500
+198,600
+89% +$1.48M
HBB icon
39
Hamilton Beach Brands
HBB
$422M
$2.56M 0.61%
115,044
+35,220
+44% +$769K
IMMR icon
40
Immersion
IMMR
$252M
$2.44M 0.59%
+278,564
New +$2.39M
LEXX icon
41
Lexaria Bioscience
LEXX
$8.71M
$2.22M 0.53%
21,141
+1,401
+7% +$125K
NEU icon
42
NewMarket
NEU
$8.18B
$2.22M 0.53%
+6,892
New +$2.41M
BDC icon
43
Belden
BDC
$5.19B
$2.21M 0.53%
+43,640
New +$2.13M
SENEA icon
44
Seneca Foods Class A
SENEA
$1.21B
$2.04M 0.49%
39,893
+20,263
+103% +$978K
TROX icon
45
Tronox
TROX
$1.04B
$1.83M 0.44%
81,542
-39,418
-33% -$865K
OVV icon
46
Ovintiv
OVV
$16.4B
$1.79M 0.43%
+56,985
New +$1.53M
VHI icon
47
Valhi
VHI
$450M
$1.78M 0.43%
73,193
-8,364
-10% -$217K
PRTH icon
48
Priority Technology Holdings
PRTH
$444M
$1.71M 0.41%
224,247
+23,102
+11% +$166K
TEN
49
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$1.7M 0.41%
88,029
-20,445
-19% -$306K
CCS icon
50
Century Communities
CCS
$2.03B
$1.7M 0.41%
+25,467
New +$1.8M
1
2
3 4 5

Similar funds

SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
CAG
Csenge Advisory Group Clearwater, Florida $2.18B AUM 16.73% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM
ET
Entropy Technologies New York $2.17B AUM 21.46% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
MIAS
Mason Investment Advisory Services Reston, Virginia $2.17B AUM 28.39% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
IIP
Intermede Investment Partners London, United Kingdom $2.16B AUM 18.47% 1-Year Est. Return

Invenomic Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Invenomic Capital Management held 163 positions worth $418M, down 6.9% from $448M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Invenomic Capital Management withdrew a net $37.5M in Q2 2021, closing 39 positions and reducing 48 holdings. Its most notable exit was UGI, an estimated $3.26M position sold in full.

By sector, the portfolio is most concentrated in Financials at 9.1% of assets, up from 6.9% a quarter earlier, followed by Industrials and Materials.

Against the trend, Invenomic Capital Management opened a new position in Popular Inc worth $3.23M.

  • Invenomic Capital Management's largest Q2 2021 buy was Popular Inc: 43,078 shares worth $3.23M.
  • Invenomic Capital Management added most to Surgalign Holdings, Inc. Common Stock in Q2 2021, an estimated $3.75M increase.
  • Invenomic Capital Management's biggest Q2 2021 reduction was Molson Coors Class B, cutting an estimated $3.57M.
  • Invenomic Capital Management fully exited UGI in Q2 2021, selling an estimated $3.26M.
  • Invenomic Capital Management's ten largest holdings make up 54% of its $418M portfolio in Q2 2021.
  • Invenomic Capital Management opened 44 new positions and closed 39 in Q2 2021.
  • Invenomic Capital Management's portfolio value fell 6.9% quarter-over-quarter to $418M.

Based on Invenomic Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.